Hanmei Xu
China Pharmaceutical University(CN)
Publications by Year
Research Areas
Cancer-related molecular mechanisms research, RNA modifications and cancer, Angiogenesis and VEGF in Cancer, MicroRNA in disease regulation, Extracellular vesicles in disease
Most-Cited Works
- → Trends in insulin resistance: insights into mechanisms and therapeutic strategy(2022)745 cited
- → Functional Role of a Novel Long Noncoding RNA TTN-AS1 in Esophageal Squamous Cell Carcinoma Progression and Metastasis(2017)164 cited
- → NK cell-derived exosomes carry miR-207 and alleviate depression-like symptoms in mice(2020)155 cited
- → Nucleic acid drugs: recent progress and future perspectives(2024)106 cited
- → Natural killer cell-derived exosomal miR-1249-3p attenuates insulin resistance and inflammation in mouse models of type 2 diabetes(2021)87 cited
- → Potential therapeutic applications of exosomes in different autoimmune diseases(2019)77 cited
- → Antisense oligonucleotides targeting lncRNA AC104041.1 induces antitumor activity through Wnt2B/β-catenin pathway in head and neck squamous cell carcinomas(2020)73 cited
- → Tumor-Derived EV-Encapsulated miR-181b-5p Induces Angiogenesis to Foster Tumorigenesis and Metastasis of ESCC(2020)57 cited
- → Cancer-related micropeptides encoded by ncRNAs: Promising drug targets and prognostic biomarkers(2022)54 cited
- → Mining for missed sORF-encoded peptides(2019)45 cited